Gayón VE, Hernández OH, Sam SS, Lombardo AE

Language: Spanish
References: 27
Page: 88-96
PDF size: 183.59 Kb.

ABSTRACT

Background: Sexual transmitted diseases (included HIV/AIDS) are a common and preventable cause of perinatal morbidity and mortality. When used consistently and correctly, condoms are effective to prevent these diseases, however, its protection does not account for 100%.
Objective: To know the effectiveness of male condom, through bibliographic evidence, to prevent sexual transmitted infections in heterosexual serodiscordant partners.
Material and methods: A bibliographical review of Medline/Pubmed, LILACS and Cochrane databases, and publications of the National Health Institutes, Centers for Disease Control and Prevention, World Health Organization, and WHO AIDS Global Program was done to analyze male condom effectiveness to prevent sexual transmitted diseases.
Results: Reports demonstrated that male condom protection against HIV/AIDS in heterosexual serodiscordant partners goes from 60 to 95%. Most recent information (2006) showed 80%. Two studies demonstrated no HPV protection with male condom, and another one 70% of protection. Male condom demonstrated no HPV-1 protection, but decrease of risk in HVS-2 transmission in women (0.85 of protection).
Conclusion: Male condom protection against sexual transmitted diseases is not 100%. There must be used additional measures that have demonstrated its utility to decrease transmission risk.

REFERENCES

1. National Institute of Allergy and Infectious Diseases. Workshop Summary: Evidence on Condom Effectiveness for Sexually Transmitted Disease (STD) Prevention, 2000.

2. Ortíz-Ibarra FG, Piazola-Camacho NG. Síndrome de inmunodeficiencia adquirida (SIDA). En: Casanova RG, Ortíz Ibarra FJ, Reyna Figueroa J, editores. Infecciones de trasmisión sexual. 1ª ed. México: Alfil, 2004;pp:41-48.

3. Centers for Disease Control and Prevention. Sexually Transmitted Diseases. Treatment Guidelines 2006.[accesado en diciembre 2006]: Disponible en URL: [Consulta: diciembre 2006].

4. Weller S, Davis K. Efectividad del condón en la reducción de la trasmisión de VIH en heterosexuales (Cochrane Review). In: The Cochrane Library, Issue 1, 2006. Oxford: Update Software.

5. Cates W. The NIH condom report: The glass is 90% full. Fam Plann Perspect 2001;33(5):231-3.

6. Frezieres RG, Walsh TL, Nelson AL, Clark VA, Coulson AH. Evaluation of the efficacy of polyurethane condom: results from randomized, control trial. Fam Plann Perspect 1999;31(2):73-78.

7. Weller SC. A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med 1993;36:1635-44.

8. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997;44:1303-12.

9. Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999:31(6):272-9.

10. Vasconcelos-Allende M, Aranda C, Ruiz-Moreno JA, Paz- Fuentes E. Búsqueda, detección y control del virus del papiloma humano (VPH). Ginecol Obstet Mex 1992;60:37-41.

11. Centers for Disease Control and Prevention. Fact sheet for public health personnel: male latex condoms and sexually transmitted diseases. Dirección URL:. [Consulta: diciembre 2006].

12. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A metaanalysis. Sex Trans Dis 2002;29:725-35.

13. Winer RL, Hughes JP, Qinghua F, O’Reilly S, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645-54.

14. Hogewoning CJ, Bleeker MG, van den Brule AJ, Voorhorst FJ, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003;107(5):811-6.

15. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ (online) 2004;82(6):454-61.

16. Wald A, Langenberg AGM, Link K, Izu AE, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100-6.

17. Wald A, Langenberg AG, Krantz E, Douglas JM, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005;143(10):707-13.

18. Sánchez J, Campos PE, Courtois B, Gutierrez L, et al. Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sex Transm Dis 2003;30(4):273-9.

19. Crosby RA, DiClemente RJ, Wingwood GM, Lang D, Harrington KF. Value of consistent condom use: a study of sexually transmitted disease prevention among African American adolescent females. Am J Pub Health 2003;93:901-2.

20. Plazola-Camacho NG, Figueroa-Damián R. Sífilis. En: Casanova RG, Ortíz Ibarra FG, Reyna FJ, editores. Infecciones de trasmisión sexual. México: Alfil, 2004;pp:199-214.

21. Ahmed S, Lutalo T, Wawer M, Serwadda D, et al. HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakay, Uganda. AIDS 2001;15:2171-9.

22. Trusell J, Hatcher RA, Cates W, Hance SF, Kost K. Contraceptive failure in the United States: an update. Stud Fam Plan 1990; 21(1):51-54.

23. Ranjit N. Contraceptive failure in the first two years of use: differences across socioeconomic groups. Famm Plann Perspect 2001;33(1):19-27.

24. UNAIDS 2004 Report on the Global AIDS Epidemic. Dirección URL: . [Consulta: agosto 2006].

25. Murphy EM, Greene ME, Mihailovich A, Olupor-Olupot P. Was the “ABC” approach (abstinence, being faithful, using condoms) responsible for the Uganda’s decline in HIV? PLoS Med 2006;3(9):e379.

26. Hernández-Girón C, Cruz-Valdés A, Quiterio-Trenado M y col. Características de comportamiento sexual en hombres de la ciudad de México. Salud Publica Mex 1999;41(2):95-100.

27. Torres P, Walker DM, Gutiérrez JP, Bertozzi SM. Estrategias novedosas de prevención de embarazo e ITS/VIH/SIDA entre adolescentes escolarizados mexicanos. Salud Publica Mex 2006;48(4):308-16.